Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3858-3868
Author(s):
Manfredi Rizzo, Marcin Barylski, Ali A. Rizvi, Giuseppe Montalto, Dimitri P. Mikhailidis and Maciej Banach
Mitochondria in Cancer Stem Cells: A Target for Therapy
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
7
Page:
102-114
Author(s):
Rute Loureiro, Katia A. Mesquita, Paulo J. Oliveira and Ignacio Vega-Naredo
The Wnt Pathway: Emerging Anticancer Strategies
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
7
Page:
138-147
Author(s):
Aman Gupta, Anukriti Verma, Ashutosh K. Mishra, Gulshan Wadhwa, Sanjeev K. Sharma and Chakresh K. Jain
RNAi in Clinical Studies
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1801-1816
Author(s):
P. Kubowicz, D. Zelaszczyk and E. Pekala
Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1858-1886
Author(s):
Jiyang Li, Guangqiang Li and Wenqing Xu
Validation and Development of N-glycan as Biomarker in Cancer Diagnosis
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
11
Page:
53-58
Author(s):
Wei Wang
Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Journal:
Current Drug Delivery
Volume:
10
Page:
208-240
Author(s):
Sorin Emilian Leucuta
Redox Homeostasis and Epigenetics in Non-alcoholic Fatty Liver Disease (NAFLD)
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
2737-2746
Author(s):
Christine Podrini, Michela Borghesan, Azzura Greco, Valerio Pazienza, Gianluigi Mazzoccoli and Manlio Vinciguerra
Recent Advances in Carbon Nanotubes as Delivery Systems for Anticancer Drugs
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1333-1354
Author(s):
Daniela Iannazzo, Anna Piperno, Alessandro Pistone, Giovanni Grassi and Signorino Galvagno
Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
175-187
Author(s):
Xiaobei Zhang, Xi-ru Li and Jin Zhang